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ABSTRACT:
Introduction: As suggested through several autopsy studies there is a high prevalence of latent prostate  cancer in 
the population. A much smaller proportion of prostate  cancer is detected because of clinical symptoms. This study 
was done to identify the rates of incidentally detected prostate cancer in patients undergoing surgical management 
of Benign Prostatic Hyperplasia (BPH) in our centre. Methods: A retrospective review was done on all transurethral 
resections of the prostate (TURP)  cases from May 2014 to May 2015 at a single tertiary care institution. One hundred 
and three men, aged 40 to 88 year, underwent TURP and their specimens were sent for the  histopathological analysis. 
Results: Five (4.85%) patients were diagnosed with the prostate  cancer. All the five patients had Gleason score of 
seven or more. Two patients had moderately differentiated adenocarcinoma  with Gleason score of seven. Three 
patients had poorly differentiated adenocarcinoma with Gleason score of eight or above. The Prostate cancer was seen 
only  in the age group above 65 years but it was not statistically significant. Conclusion: Our series demonstrated 
that 4.85% of patients had latent prostate  cancer. It occurs mainly in men above 65 years of age though this was not 
statistically significant.
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INTRODUCTION:
Prostate cancer is the fourth leading 
cancer in both gender and the second most common 
cancer in male. The incidence of prostate cancer is on 
the rise. The reasons for the increase of this disease 
are not known, but increasing life expectancy and 
modified diagnostic techniques have been suggested 
as causes.1
The landmark study by Bill-Axelson et 
al. in 2011, confirmed early prostatectomy was 
significantly associated with reduced mortality 
when compared with watchful waiting.2 At 23 year 
follow up, men aged ≤65 years experienced the 
greatest oncological benefit, with a reduction in 
overall mortality of 25.5% and a prostate cancer 
death reduction of 15.8% following prostatectomy.3 
Furthermore, this study reported that in men aged 
≤65 years, the number needed to treat to avert one 
death was only four. These findings suggest that 
early prostate cancer diagnosis and management is 
critical in this younger population.
Prostate cancer isolated exclusively in the 
transitional zone (TZ) is uncommon, accounting 
for only 2-7% of all prostate cancers.4-6 Several 
recent studies have reported that cancer arising 
from the TZ have a more favorable prognosis than 
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tumors that arise in the peripheral zone (PZ).4 As a 
result, several groups argue that the trans-urethral 
resection of prostate (TURP) specimen may hold 
limited diagnostic value.7 With an increase in PSA 
screening, there has been a decrease in incidence 
of carcinoma prostate. The reason being adoption 
of new technologies do not always provide tissue 
for pathological examination leading to potentially 
missed cancers. Some incidental prostate cancers 
have been shown to be clinically relevant, specifically 
tumors with a higher Gleason score and stage pT1b.8
In the context of current screening practices and 
changing practice patterns, we sought to identify 
the rates of incidentally detected prostate cancer in 
TURP specimens.
METHODS:
 After obtaining Institutional Review 
Committee (IRC) approval, a retrospective review 
was performed on all cases of transurethral resection 
of the prostate that provided a tissue specimen 
between 15th May 2014 to 14th May 2015. One 
hundred and three men, aged from 40 to 88 years, 
were identified as having BPH who underwent 
TURP. The patients were divided into two groups 
i.e. one group consisting of patients younger than 65 
years and the other group being 65 years or more. 
The data were retrieved from the hospital records. 
Demography details, findings of digital rectal 
examination (DRE), PSA value and histopathological 
results were recorded. Patients with a preoperative 
diagnosis of prostate  cancer were excluded from the 
analysis.
 Data were tabulated in Microsoft excel sheet 
and was analyzed in SPSS 21. Frequencies and 
percentages were calculated for descriptive data 
meanwhile Pearson Chi-square test was used to 
compare the association between categorical data. P 
value less than 0.05 was considered significant.
RESULTS:
 There were a total of 103 patients with 
majority of patients (n=75, 72.8%) 65 years of age 
or older. This difference was statistically significant 
(X2[N=103, df=1] = 21.4, p<.001). 
 Ninety-five (92.2%) patients were 
histologically diagnosed as having BPH. Forty-five 
had BPH with chronic prostatitis and one patient was 
diagnosed to have prostatic intraepithelial neoplasia. 
Other two had prostatic abscess and necrotic tissue 
respectively.
 Five (4.8%) patients, all above 65 yr of age, 
were diagnosed with prostate cancer. Two of them 
had moderately differentiated adenocarcinoma 
with Gleason score of seven and three had poorly 
differentiated adenocarcinoma with Gleason score 
more then seven. Fisher exact test was applied to 
see the relation between age group and occurrence 
of incidental prostate cancer and there was no 
significant difference in cancer occurrence in those 
age-group (p=.32).
 
DISCUSSION:
 Our study showed an incidental prostate 
cancer rate of 4.8% the Gleason sum of which 
ranged from 7 to 9. This detection rate is lower than 
several other recently published series; however, it 
is consistent with the overall decrease in incidental 
prostate cancer in the PSA era. Mai et al. showed 
similar results in their review of almost 1000 TURP 
specimens. They found significant decreases in the 
overall detection rate, 12.9 to 8%, and the amount of 
pT1b lesions, 10% to 5%.9 More recently, Jones et al. 
found a decrease of incidental prostate cancer from 
14.9% to 5.2% (pre versus post PSA era) in over 700 
patients.10 They saw significant decreases in both 
pT1a and pT1b incidental prostate cancer (4.4% to 
2.2% and 10.5% to 2.8%, respectively) between the 
pre-PSA and the PSA era. Other possible reasons for 
the reduction in incidental prostate cancer include 
the decreased rate of surgical management of BPH 
due to increased use of medical therapy as well as 
an increased use of ablative therapies, which do 
not always provide tissue for pathologic analysis in 
patients who ultimately require surgical management 
of their BPH.11,12
 Several studies, in addition to ours, have 
looked at the incidental prostate cancer rate in the 
PSA era. Prior to our findings, detection rates in 
the PSA era ranged from 4.8% to 16.7%.8-11,13-15 
Dellavedova et al. found an incidental prostate 
cancer detection rate of 7% when they reviewed 100 
patients who underwent bipolar TURP.11 Six patients 
had Gleason grade 3+3 pT1a disease and one patient 
had Gleason grade 3+4 pT1b disease. Helfand et al. 
studied the postoperative changes in PSA and PSA 
velocity in patients undergoing surgical management 
of BPH, they found an incidental prostate cancer rate 
of 8.7% in 313 patients who underwent monopolar 
or bipolar TURP.13 Twenty patients had pT1a disease 
and 10 had pT1b disease. They also showed that 
postoperative PSA values decreased less and PSA 
velocity was higher in patients who had incidental 
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prostate cancer compared to BPH.13 Voigt et al. 
found an incidental prostate cancer rate of 11.1% in 
their study trying to identify risk factors for clinically 
relevant prostate cancer discovered incidentally.8 
3.4% of the patients in their series had clinically 
relevant prostate cancer, pT1b, or Gleason grade 
7–10 disease. Trpkov et al. have reported the highest 
incidental prostate cancer rate (16.7%) in the PSA era; 
however, their study included patients with known 
prostate cancer.14 A recent multi-centric review by 
Yoo et al. showed an incidental prostate cancer rate 
of 4.8% in over 1600 patients.15 They found that 
in addition to DRE findings, the combination of 
transitional zone volume and PSA could be useful 
predictors of incidental prostate cancer. Overall, 
these studies continue to support both a decreased 
overall prevalence of incidental prostate cancer and 
more specifically pT1b lesions in the modern era. In 
addition, they support the use of technologies that 
do not provide tissue for pathologic examination at 
the time of BPH surgical management. Besides this, 
the importance of diagnosis of prostate cancer in 
younger males is well established in contemporary 
urological practice.16 But in our study, none of 
the patient had incidental detection of carcinoma 
prostate in population younger than 65 yrs. However 
in a study conducted by Marlon Perera, prostate 
cancer was diagnosed in 13.4% of the younger 
group and 28.7% in the older group.17 The younger 
group had a higher proportion of low-volume 
disease (pT1a). Of the diagnosed prostate cancers, 
the 92.2% were of acinar adenocarcinoma subtype, 
with similar proportions between subgroups. Within 
the younger group, a significantly higher rate of low-
grade prostate cancer was diagnosed (Gleason score 
6). None of the younger patients were diagnosed 
having carcinoma prostate in our study but it was 
not statistically significant.
CONCLUSIONS:
 We demonstrated an incidental prostate 
cancer rate of 4.8% in this PSA era and prostate 
cancer was seen only in population older than 65 
years though not statistically significant.
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